Financing channel feed – Endpoints News

Financing channel feed

Radioligands are going on air: Aktis gains third Big Pharma backer

3 years ago

Searching for new TCR targets, immunotherapy startup emerges with Stanford tech, $40M round

3 years ago

Natalie Holles tests the Nasdaq waters with Third Harmonic IPO

3 years ago

Biotech's 'sugar high' led to a correction, but winter doldrums could make way for a turnaround story this fall

3 years ago

Psychedelics startup nets more than $10M in seed funding as it looks to make a splash

3 years ago

Mereo's biggest shareholder eyes major changes amid stock falloff

3 years ago

Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers

3 years ago

Kymera opens up $150M PIPE financing, thanks to unexpected offer from investors

3 years ago

Almac commits to $65M expansion for its Pennsylvania HQ amid wider investments

3 years ago

Former Google CEO’s VC is making a bigger push into the biotech world, hiring prominent Theranos skeptic

3 years ago

Novartis-partnered biotech nabs new cash, boosting efforts to develop 'functional cure' for chronic hepatitis B

3 years ago

Updated: EU's lending arm grants Polish biotech $22M+ in debt financing to advance pipeline

3 years ago

Positive readout? Public offering: Viridian plans to raise $175M on eye disease therapy data

3 years ago

Gossip in Babylon: Digital health company paints M&A rumors as flat-out wrong

3 years ago

Buying time to catch up on sales, ADC Therapeutics takes on $175M loan

3 years ago

Two years post-merger, Flagship’s Senda refines pipeline and replenishes the bank

3 years ago

Atai prunes pipeline, drops out of partnerships as it takes on $175M loan and focuses on looming data readouts

3 years ago

You can add a colorful Australian mining tycoon to the list of billionaires betting on biotech

3 years ago

David Baker lab spinout scores seed funding to build a biosensor from engineered protein

3 years ago

Carlyle finds its first big biotech bet after teaming with Abingworth

3 years ago

Cerevel's Tony Coles is still counting his money as a rival's boost helps fuel a potential $609M windfall

3 years ago

Following the recent playbook, CinCor raises $225M on back of positive PhII readout

3 years ago

Cerevel takes the public offering route, with a twist — raising big money thanks to rival data

3 years ago

Updated: 'Close to the middle': Versant launches Vector with 'gutless adenovirus' delivery method

3 years ago

First page Previous page 48 49 505152 53 54 Next page Last page